Report DMCA Preferential solvation and solvation shell composition of sunitinib malate, an anti-tumor compound, in some binary mixed
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.
* Please fill this form as much details as possible, we will respond to your request within 2 to 3 business days.